MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
OCS Oculis
- 16.980
- -0.030-0.18%
Close Dec 20 16:00 ET
712.23MMarket Cap-9.53P/E (TTM)
17.055High16.980Low14.52KVolume17.010Open17.010Pre Close246.97KTurnover0.04%Turnover RatioLossP/E (Static)41.94MShares18.00052wk High6.72P/B674.83MFloat Cap10.10552wk Low--Dividend TTM39.74MShs Float18.000Historical High--Div YieldTTM0.44%Amplitude6.260Historical Low17.004Avg Price1Lot Size
About Oculis Company
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Company Profile
SymbolOCS
Company NameOculis
Listing DateMay 13, 2021
Founded2016
CEODr. Riad Sherif, M.D.
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
AddressBahnhofstrasse 7
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-58-810-01-82
Websitehttp://oculis.com
Company Executives
- Name
- Position
- Salary
- Dr. Riad Sherif, M.D.
- Chief Executive Officer and Director
- --
- Sylvia Cheung
- Chief Financial Officer
- --
- Pall Ragnar Johannesson
- Chief Business Officer
- --
- Anthony A. Rosenberg
- Chairman of the Board
- --
- Pravin Dugel
- Independent Director
- --
- Geraldine O’Keeffe
- Independent Director
- --
- Christina M. Ackermann
- Independent Director
- --
- Martijn Kleijwegt
- Independent Director
- --
- Lionel Carnot
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.